FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 179 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR Mom’s Early-Stage Breast Cancer Discovered When She Undergoes Testing to Donate... August 21, 2019 Begin Each Day… January 20, 2021 “Chameleon-Like” Breast Cancer Cells Disguised as Neurons Can Lead to Brain... June 8, 2021 EMA Recommends Extension of Indications for Trastuzumab Deruxtecan to Include Treatment... March 21, 2025 Load more HOT NEWS A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target... On your marks, get set… start-up! Woman Develops Breast Cancer After Double Mastectomy, Has to Have the... Patient Guide in Prostate Cancer Now Available Also in German
